Results 251 to 260 of about 487,324 (300)
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Acinetobacter spp. in food and drinking water - A review.
Food Microbiology, 2021Acinetobacter spp. has emerged as a pathogen of major public health concern due to their increased resistance to antibiotics and their association with a wide range of nosocomial infections, community-acquired infections and war and natural disaster-related infections.
A. Carvalheira +2 more
semanticscholar +4 more sources
Enrichment of Acinetobacter spp. from food samples
Food Microbiology, 2016Relatively little is known about the role of foods in the chain of transmission of acinetobacters and the occurrence of different Acinetobacter spp. in foods. Currently, there is no standard procedure to recover acinetobacters from food in order to gain insight into the food-related ecology and epidemiology of acinetobacters. This study aimed to assess
Carvalheira, Ana +3 more
openaire +3 more sources
Journal of Basic Microbiology, 2019
Bioemulsifiers (BE) and biosurfactants (BS) are considered as multifunctional biomolecules of 21st century because of their functional abilities and eco‐friendly properties.
S. Mujumdar, P. Joshi, Neha Karve
semanticscholar +1 more source
Bioemulsifiers (BE) and biosurfactants (BS) are considered as multifunctional biomolecules of 21st century because of their functional abilities and eco‐friendly properties.
S. Mujumdar, P. Joshi, Neha Karve
semanticscholar +1 more source
Acinetobacter baumannii and Acinetobacter spp.
2017Acinetobacter baumannii is a bacterial pathogen increasingly identified in the clinical microbiology laboratory as a cause of infection in humans. Upon microscopic examination, A. baumannii appears as a Gram-negative coccobacillus, and it produces clear colonies when grown on MacConkey agar, indicating its inability to ferment lactose.
Federico Perez, Robert A. Bonomo
openaire +1 more source
Treatment of Acinetobacter spp. infections
Expert Opinion on Pharmacotherapy, 2003Acinetobacter spp. are predominantly nosocomial pathogens of growing importance. One of their important features is antimicrobial resistance that includes beta-lactams, aminoglycosides and quinolones. Imipenem, considered the most effective drug against Acinetobacter spp., is not universally active against clinical isolates and therapeutic options are ...
openaire +2 more sources

